Cubist Systematic Strategies, LLC Merck & Co., Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.6 Billion
Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 150,800 shares of MRK stock, worth $11.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

150,800

Previous 23,906 530.8%

Holding current value

$11.6 Million

Previous $2.38 Million 469.18%

% of portfolio

0.09%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$96.31 - $114.76 $32.2 Million - $38.3 Million	-334,086 Reduced 93.32%	23,906 $2.38 Million
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $4.12 Million - $4.78 Million	37,052 Added 11.54%	357,992 $40.7 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $34.2 Million - $36.7 Million	276,246 Added 618.08%	320,940 $39.7 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $5.06 Million - $5.9 Million	44,694 New	44,694 $5.9 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $31.1 Million - $34.6 Million	302,448 New	302,448 $31.1 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $7.39 Million - $8.25 Million	-71,826 Reduced 75.55%	23,243 $2.47 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $4.46 Million - $5.72 Million	-51,045 Reduced 34.94%	95,069 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $8.86 Million - $9.96 Million	-104,873 Reduced 41.78%	146,114 $12.6 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $8.86 Million - $9.96 Million	-104,873 Reduced 41.78%	146,114 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $3.59 Million - $4.07 Million	42,962 Added 20.65%	250,987 $22.9 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $826,913 - $926,917	11,249 Added 5.72%	208,025 $17.1 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $12.1 Million - $15.1 Million	166,808 Added 556.62%	196,776 $15.1 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $661,176 - $727,127	-9,224 Reduced 23.54%	29,968 $2.25 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $24.4 Million - $27 Million	-346,854 Reduced 89.85%	39,192 $3.05 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $6.13 Million - $7.22 Million	88,971 Added 29.95%	386,046 $29.8 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $5.38 Million - $5.97 Million	74,959 Added 33.75%	297,075 $24.3 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $12 Million - $13.7 Million	164,621 Added 286.32%	222,116 $18.4 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $12.9 Million - $14.7 Million	-183,238 Reduced 76.12%	57,495 $4.45 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $11.6 Million - $16.1 Million	183,682 Added 321.96%	240,733 $18.5 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $3.87 Million - $4.37 Million	-49,920 Reduced 46.67%	57,051 $5.19 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $6.74 Million - $7.35 Million	-88,586 Reduced 45.3%	106,971 $9.01 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $13.4 Million - $15.6 Million	191,422 Added 4629.31%	195,557 $16.4 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $185,639 - $211,732	-2,668 Reduced 39.22%	4,135 $344,000
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $2.11 Million - $2.45 Million	-32,329 Reduced 82.62%	6,803 $520,000
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $121,668 - $143,074	-2,109 Reduced 5.11%	39,132 $2.78 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $220,500 - $259,065	-4,338 Reduced 9.52%	41,241 $2.5 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $1.25 Million - $1.45 Million	-24,546 Reduced 35.0%	45,579 $2.48 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $397,732 - $474,936	7,705 Added 12.34%	70,125 $3.95 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $3.66 Million - $3.94 Million	62,420	62,420 $4 Million

Others Institutions Holding MRK

# of Institutions

3,892

Shares Held

1.93B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $195B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Merck & Co., Inc. Transaction History